Anavex Life Sciences
AVXL
#8359
Rank
NZ$0.42 B
Marketcap
NZ$4.61
Share price
-0.55%
Change (1 day)
-63.35%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -NZ$80.65 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$88.11 Million a decrease over its 2023 earnings that were of -NZ$76.77 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$80.65 Million-8.46%
2024 -NZ$88.11 Million14.77%
2023 -NZ$76.77 Million-17.49%
2022 -NZ$93.05 Million22.96%
2021 -NZ$75.67 Million35.36%
2020 -NZ$55.9 Million12.65%
2019 -NZ$49.63 Million29.09%
2018 -NZ$38.44 Million36.33%
2017 -NZ$28.2 Million17.11%
2016 -NZ$24.08 Million20.91%
2015 -NZ$19.92 Million-6.29%
2014 -NZ$21.25 Million337.28%
2013 -NZ$4.86 Million
2008 -NZ$8.99 Million106.01%
2007 -NZ$4.37 Million8848.98%
2006 -NZ$0.05 Million-79.99%
2005 -NZ$0.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.27 B-449.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$12.37 M-115.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$8.2 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$0.45 B-671.48%๐Ÿ‡บ๐Ÿ‡ธ USA